Increased level of platelet microparticles in survivors of myocardial infarction

References

• Gawaz M. Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium. Cardiovasc Res 2004; 61: 498–511
   PubMed Web of Science ®Google Scholar
• Martin J. F., Trowbridge E. A., Salmon G., Plumb J. The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear ONA concentration. Thromb Res 1983; 32: 443–60
   PubMed Web of Science ®Google Scholar
• Sharp D. S., Bath P. M. W., Martin J. F., Beswick A. D., Sweetnam P. M. Platelet and erythrocyte volume and count: epidemiological predictors of impedance measured AOP‐induced platelet aggregation in whole blood. Platelets 1994; 5: 252–7
   PubMed Web of Science ®Google Scholar
• Cameron H. A., Phillips R., Ibbotson R. M., Carson P. H. Platelet size and myocardial infarction. Br Med J 1983; 287: 449–51
   PubMed Web of Science ®Google Scholar
• Martin J. F., Plumb J., Kilbey R. S., Kishk Y. T. Changes in volume and density of platelets in myocardial infarction. Br Med J 1983; 287: 456–9
   PubMed Web of Science ®Google Scholar
• Endler G., Klimesch A., Sunder‐Plassmann H., Schillinger M., Exner M., Mannhalter C., et al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 2002; 117: 399–404
   PubMed Web of Science ®Google Scholar
• Bath P., Algert C., Chapman N., Neal B. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 2004; 35: 622–6
   PubMed Web of Science ®Google Scholar
• Martin J. F., Bath P. M., Burr M. L. Influence of platelet size on outcome after myocardial infarction. Lancet 1991; 338: 1409–11
   PubMed Web of Science ®Google Scholar
• Bode A. P., Sandberg H., Dombrose F. A., Lentz B. R. Association of factor V activity with membranous vesicles released from human platelets: requirement for platelet stimulation. Thromb Res 1985; 39: 49–61
   PubMedGoogle Scholar
• Sims P. J., Faioni E. M., Wiedmer T., Shattil S. J. Complement proteins C5b‐9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 1988; 263: 18205–12
   PubMed Web of Science ®Google Scholar
• Holme P. A., Brosstad F., Solum N. O. Platelet‐derived microvesicles and activated platelets express factor Xa activity. Blood Coagul Fibrinolysis 1995; 6: 302–10
   PubMed Web of Science ®Google Scholar
• Scholz T., Temmler U., Krause S., Heptinstall S., Losche W. Transfer of tissue factor from platelets to monocytes: role of platelet‐derived microparticles and CD62P. Thromb Haemost 2002; 88: 1033–8
   PubMed Web of Science ®Google Scholar
• George I. N., Pickett E. B., Saucerman S., McEver R. P., Kunicki T. J., Kieffer N., et al. Platelet surface glycoprotein. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest 1986; 78: 340–8
   PubMed Web of Science ®Google Scholar
• Iwamoto S., Kawasaki T., Kambayashi J., Ariyoshi H., Monden M. Platelet microparticles: a carrier of platelet‐activating factor?. Biochem Biophys Res Commun 1996; 218: 940–4
   PubMed Web of Science ®Google Scholar
• Mause S. F., von Hundelshausen P., Zernecke A., Koenen R. R., Weber C. Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol 2005; 25: 1512–18
   PubMed Web of Science ®Google Scholar
• Holme P. A., Solum N. O., Brosstad F., Roger M., Abdelnoor M. Demonstration of platelet‐derived microparticles in blood from patients with activated coagulation and fibrinolysis using a filtration technique and Western blotting. Thromb Haemost 1994; 72: 666–71
   PubMed Web of Science ®Google Scholar
• Kelton J. G., Warkentin T. E., Hayward C. P., Murphy W. G., Moore J. C. Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles. Blood 1992; 80: 2246–51
   PubMed Web of Science ®Google Scholar
• Warkentin T. E., Hayward C. P., Boshkov L. K., Santos A. V., Sheppard J. A., Bode A. P., et al. Sera from patients with heparin‐induced thrombocytopenia generate platelet‐derived microparticles with Procoagulant activity: an explanation for the thrombotic complications of heparin‐induced thrombocytopenia. Blood 1994; 84: 3691–9
   PubMed Web of Science ®Google Scholar
• Preston R. A., Jy W., Jimenez J. J., Mauro L. M., Horstman L. L., Valle M., et al. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 2003; 41: 211–17
   PubMed Web of Science ®Google Scholar
• Nomura S., Komiyama Y., Miyake T., Miyazaki Y., Kido H., Suzuki M., et al. Amyloid beta‐protein precursor‐rich platelet microparticles in thrombotic disease. Thromb Haemost 1994; 72: 519–22
   PubMed Web of Science ®Google Scholar
• Nomura S., Suzuki M., Katsura K., Xie G., Miyazaki Y., Miyake T., et al. Platelet‐derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis 1995; 116: 235–40
   PubMed Web of Science ®Google Scholar
• Nomura S., Uehata S., Saito S., Osumi K., Ozeki Y., Kimura Y. Enzyme immunoassay detection of platelet‐derived microparticles and RANTES in acute coronary syndrome. Thromb Haemost 2003; 89: 506–12
   PubMed Web of Science ®Google Scholar
• Morel O., Hugel B., Jesel L., Lanza F., Douchet M. P., Zupan M., et al. Sustained elevated amounts of circulation procoagulant membrane microparticles and soluble GPV after acute myocardial infarction in diabetes mellitus. Thromb Haemost 2004; 91: 345–53
   PubMedGoogle Scholar
• Matsumoto N., Nomura S., Kamihata H., Kimura Y., Iwasaka T. Increased level of oxidized LDL‐dependent monocyte‐derived microparticles in acute coronary syndrome. Thromb Haemost 2004; 91: 146–54
   PubMed Web of Science ®Google Scholar
• Schonbeck U., Varo N., Libby P., Buring J., Ridker P. M. Soluble CD40L and cardiovascular risk in women. Circulation 2001; 104: 2266–8
   PubMed Web of Science ®Google Scholar
• Michelsen A. E., Wergeland R., Stokke O., Brosstad F. Development of a time‐resolved immunofluorometric assay for quantifying platelet‐derived microparticles in human plasma. Thromb Res 2006; 117: 705–11
   PubMedGoogle Scholar
• Heijnen H. F. G., Schiel A. E., Fijnheer H., Geuze H. J., Sixma J. J. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and apha‐granules. Blood 1999; 94: 3791–9
   PubMed Web of Science ®Google Scholar
• Burstein M., Scholnick H. R., Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970; 11: 583–95
   PubMed Web of Science ®Google Scholar
• Friedewald W. T., Levy R. I., Fredrickson O. S. Estimation of the concentration of low‐density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• de Man F. H., Nieuwland R., van der Laarse A., Romijn F., Smelt A. H., Gevers Leuven J. A., et al. Activated platelets in patients with severe hypertriglyceridemia: effects of triglyceride‐lowering therapy. Atherosclerosis 2000; 152: 407–14
   PubMed Web of Science ®Google Scholar
• Broijersen A., Karpe F., Hamsten A., Goodall A. H., Hjemdahl P. Alimentary lipemia enhances the membrane expression of platelet P‐selectin without affecting other markers of platelet activation. Atherosclerosis 1998; 137: 107–13
   PubMed Web of Science ®Google Scholar
• Hyson D. A., Paglieroni T. G., Wun T., Rutledge J. C. Postprandial lipemia is associated with platelet and monocyte activation and increased monocyte cytokine expression in normolipemic men. Clin Appl Thromb Hemost 2002; 8: 147–55
   PubMed Web of Science ®Google Scholar
• Pernerstorfer T., Stohlawetz P., Stummvoll G., Kapiotis S., Szekeres T., Eichler H. G., et al. Low‐dose aspirin does not lower in vivo platelet activation in healthy smokers. Br J Haematol 1998; 102: 1229–31
   PubMed Web of Science ®Google Scholar
• Nair S., Kulkarni S., Camoens H. M. T., Ghosh K., Mohanty D. Changes in platelet glycoprotein receptors after smoking – a flow cytometric study. Platelets 2001; 12: 20–6
   PubMed Web of Science ®Google Scholar
• Patrono C. Aspirin as an anti‐platelet drug. N Engl J Med 1994; 330: 1287–94
   PubMed Web of Science ®Google Scholar
• Schwencke C., Schmeisser A., Weinbrenner C., Braun‐Dullaeus R. C., Marquetant R., Strasser R. H. Transregulation of the a2‐adrenergic signal transduction pathway by chronic 13‐blockade. A novel mechanism for the decreased platelet aggregation in patients. J Cardiovasc Pharmacol 2005; 45: 253–9
   PubMedGoogle Scholar
• Puccetti L., Pasqui A. L., Pastorelli M., Bova G., Cercignani M., Palazzuoli A., et al. Time‐dependent effect of statins on platelet function in hypercholesterolaemia. Eur J Clin Invest 2002; 32: 901–8
   PubMed Web of Science ®Google Scholar
• Puccetti L., Pasqui A. L., Pastorelli M., Bova G., Di Renzo M., Leo A., et al. Platelet hyperactivity after statin treatment discontinuation. Thromb Haemost 2003; 90: 476–82
   PubMed Web of Science ®Google Scholar
• VanWijk M. J., VanBavel E., Sturk A., Nieuwland R. Microparticles in cardiovascular disease. Cardiovasc Res 2003; 59: 277–87
   PubMed Web of Science ®Google Scholar
• Berckmans R. J., Neiuwland R., Boing A. N., Romijn F. P., Hack C. E., Sturk A. Cell‐derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001; 85: 639–46
   PubMed Web of Science ®Google Scholar
• Boulanger C. M., Scoazec A., Ebrahimian T., Henry P., Mathieu E., Tedgui A., et al. Circulation microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001; 104: 2649–52
   PubMed Web of Science ®Google Scholar
• Tan K. T., Tayebjee M. H., Macfadyen R. J., Lip G. Y., Blann A. D. Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammation. Platelets 2005; 16: 368–71
   PubMed Web of Science ®Google Scholar